Symbiotec Pharmalab Limited - pharma in Mhow, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24232MP2002PLC015293 Incorporated 20 September 2002 ROC Gwalior HQ Mhow, Madhya Pradesh, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹755.98 Cr
▲ 5.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹30 Cr
Registered with MCA
Paid-up capital
₹12.34 Cr
Issued & subscribed
Open charges
₹556.47 Cr
Satisfied ₹395.55 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
1,330
Latest available

About Symbiotec Pharmalab Limited

Data last updated:

Symbiotec Pharmalab Limited is a public limited company based in Mhow, Madhya Pradesh, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 20 September 2002, the company has been in operation for over 24 years.

Registered with ROC Gwalior under CIN U24232MP2002PLC015293.

Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹12.34 Cr. Formerly known as Symbiotec Pharmalab Limited. It is led by directors including Rohit Brijmohan Mantri and Pratik Patel.

Last AGM: 26 September 2024. Financial statements filed for year ended 31 March 2024. Office: Mhow, Madhya Pradesh.

As per the financials filed for FY 2025, the company reported a revenue of ₹755.98 Cr, a growth of 5% compared to the previous year.

The company has a workforce of approximately 1,330 employees as per the latest available data.

The company is associated with 1 brand - Symbiotec. As per MCA filings, the company has open charges of ₹556.47 Cr and satisfied charges of ₹395.55 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website symbiotec.in.

Company Details of Symbiotec Pharmalab Limited
CIN U24232MP2002PLC015293
Registration Number 015293
Incorporation Date 20 September 2002
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    385/2 Pigdamber, Rau, Mhow, Madhya Pradesh, India – 453331
  • Industry
    Pharma, API Manufacturers
Company report
Symbiotec Pharmalab Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Symbiotec Pharmalab Limited report

Financials, compliance, directors, charges, ownership and filings for Symbiotec Pharmalab Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Symbiotec Pharmalab

Symbiotec Pharmalab has one previous CIN (Corporate Identification Number): U24232MP2002PTC015293. The current CIN is U24232MP2002PLC015293, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232MP2002PLC015293Current
U24232MP2002PTC015293Previous

Associated Brands with Symbiotec Pharmalab

Symbiotec Pharmalab operates one associated brand: Symbiotec. Each brand links to its own profile.

BrandDescriptionWebsite
Non-sterile steroid hormone-based APIs and intermediates are manufactured.symbiotec.in

Competitors & Alternatives of Symbiotec Pharmalab

Brands and companies operating in the same space as Symbiotec Pharmalab Limited include Laurus Labs, Sterling Pharma Solutions, Provepharm Life Solutions and 4 more.

CompetitorDescriptionLocationFounded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology companyHyderabad, India, India2005
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered.Dudley, United Kingdom, United Kingdom2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals.Marseille, France, France1998
Apicore Apicore APIs are manufactured and custom synthesis services are provided.Somerset, United States, United States2004
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas.Bengaluru, India, India2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company.Noida, India, India1978
Bellen Chemistry Bellen Chemistry APIs and intermediates are researched and manufactured, specializing in heterocycles.Beijing, China, China2007

Business Activity of Symbiotec Pharmalab

The main business activity of Symbiotec Pharmalab is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details for Symbiotec Pharmalab Limited

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Board of Directors of Symbiotec Pharmalab Limited

Symbiotec Pharmalab has 6 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rohit Brijmohan MantriNominee Director06 Dec 20187 Years 9 MonthsCurrent
Pratik PatelDirector16 Dec 20250 Years 9 MonthsCurrent
Buggana HariharnathNominee Director16 Sep 20242 Years 0 MonthsCurrent
Sunita KishnaniDirector27 Nov 20250 Years 10 MonthsCurrent
Anil Kumar SatwaniOfficer In Default14 May 200521 Years 4 MonthsCurrent
Richard Patrick Findlay KennyDirector27 Nov 20250 Years 10 MonthsCurrent

Financials of Symbiotec Pharmalab Limited FY 2024 filings available

Symbiotec Pharmalab Limited reported revenue of ₹755.98 Cr (up 5.00% YoY) for FY 2025.

Revenue · FY 2025
₹755.98 Cr ▲ 5.00%
Premium access

Ten-year financial statements for Symbiotec Pharmalab Limited

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Symbiotec Pharmalab

Open charges
₹556.47 Cr
Satisfied charges
₹395.55 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹555.98 Cr
Yes Bank Limited₹0.49 Cr
State Bank of India₹0.00 Cr
Latest charge details
DateLenderAmountStatus
23 Jul 2025State Bank of India₹25,000Open
27 Sep 2024Sbicap Trustee Company Limited₹555.98 CrOpen
06 Feb 2019Yes Bank Limited₹49 LakhOpen
28 Jul 2022Axis Bank Limited₹1.99 CrSatisfied
01 Mar 2018Hdfc Bank Limited₹1.25 CrSatisfied

Total charge records: 18 View all charges

Employees and EPFO Compliance at Symbiotec Pharmalab

Employment history and EPFO contributions of people linked to Symbiotec Pharmalab.

Premium access

Employee and EPFO history for Symbiotec Pharmalab Limited

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Symbiotec Pharmalab

Premium access

GST registrations and filing compliance for Symbiotec Pharmalab Limited

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Symbiotec Pharmalab

Premium access

Credit ratings, litigation, and regulatory alerts for Symbiotec Pharmalab Limited

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Symbiotec Pharmalab

Premium access

MSME payment history for Symbiotec Pharmalab Limited

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Symbiotec Pharmalab

Premium access

Corporate group structure for Symbiotec Pharmalab Limited

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Symbiotec Pharmalab

Premium access

MCA filings and documents for Symbiotec Pharmalab Limited

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Symbiotec Pharmalab

Directors
16 Dec 2025
Pratik Patel was appointed as a Director on 16 Dec 2025 & has been associated with this company since 9 months 19 days.
Directors
27 Nov 2025
Sunita Kishnani was appointed as a Director on 27 Nov 2025 & has been associated with this company since 10 months 7 days.
Directors
27 Nov 2025
Richard Patrick Findlay Kenny was appointed as a Director on 27 Nov 2025 & has been associated with this company since 10 months 7 days.
Charges
25 Sep 2025
A charge with Sbicap Trustee Company Limited of Rs. 555.98 Cr registered on 27 Sep 2024 with Charge ID 100986513 was modified on 25 Sep 2025.
Charges
23 Jul 2025
A charge with State Bank Of India amounted to Rs. 0.00 Cr with Charge ID 101139783 was registered on 23 Jul 2025.
Charges
06 Jun 2025
A charge registered on 28 Jul 2022 via Charge ID 100604774 with Axis Bank Limited was fully satisfied on 06 Jun 2025.

Frequently Asked Questions about Symbiotec Pharmalab Limited

Symbiotec Pharmalab is an active public limited company in the pharma sector based in Mhow, Madhya Pradesh, India. It was incorporated on 20 September 2002 (24+ years old) and is registered under CIN U24232MP2002PLC015293. The company has 1,330 employees.

Symbiotec Pharmalab reported revenue of ₹755.98 Cr for FY 2025 (up 5.00% YoY).

The current directors of Symbiotec Pharmalab are:

The primary industry of Symbiotec Pharmalab is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Symbiotec Pharmalab can be reached at the registered office: 3852 Pigdamber, Rau, Mhow, Madhya Pradesh, India – 453331, or through the website symbiotec.in.

The authorised capital is ₹30 Cr, and the paid-up capital is ₹12.34 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available